New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLADÂ®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines
MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing
Initial findings from the CLOCK-MS vaccine sub-study show protective influenza antibody levels at four weeks post-vaccination in MS patients taking MAVENCLAD
In both studies, protective antibody levels were maintained or increased independent of lymphocyte counts
DARMSTADT, Germany, Feb. 25, 2021 /PRNewswire/ --
Not intended for UK and U.S. based media
Merck, a leading science and technology company, today announced the presentation of a new analysis from the MAGNIFY-MS study on MAVENCLAD ® (cladribine tablets) in patients with relapsing multiple sclerosis (RMS) at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2021, being held virtually 25-27 February 2021. The data indicate that RMS patients receiving MAVENCLAD are able to mount a response to seasonal influenza and varicella zoster vaccination.
"Understanding vaccine efficacy in MS patients is particularly important in the face of the current pandemic and the growing availability of COVID-19 vaccines," said Klaus Schmierer, Professor of Neurology at Queen Mary University of London and The Royal London Hospital, UK. "Whilst this new information is based on a small cohort of patients receiving influenza and varicella zoster vaccines, it provides physicians with preliminary evidence that patients taking MAVENCLAD are able to mount and maintain effective vaccine responses."
The retrospective analysis was conducted to evaluate the protective antibody response to seasonal influenza (n=12) and varicella zoster virus (VZV) vaccination (n=3) in patients treated with MAVENCLAD. Blood samples taken before and after vaccination were examined. In patients who received the seasonal influenza vaccine, protective antibody levels were maintained or increased for at least six months independent of lymphocyte counts measured at the time of vaccination in year 1 or 2 of MAVENCLAD treatment. In patients who received the VZV vaccine before year 1 initiation of MAVENCLAD, protective VZV antibody levels were maintained over six months post-initiation with MAVENCLAD, despite lymphocyte depletion. These results were consistent irrespective of when the patients received the vaccine relative to their MAVENCLAD treatment.
In the CLOCK-MS vaccine sub-study analysis, three relapsing remitting multiple sclerosis (RRMS) patients had received at least one dose of MAVENCLAD prior to receiving an influenza vaccine. Protective antibody levels were increased at four weeks post-vaccination in all three patients. Two of these patients, who had received treatment with MAVENCLAD two and four months prior to vaccination, were experiencing lymphopenia around the time of vaccination.
"In an ever changing world where a pandemic will likely be present for the foreseeable future, it is critical to assess the impact of common non-live vaccinations in those taking disease modifying therapies," said Maria Rivas, MD, Chief Medical Officer, Healthcare business of Merck. "We are committed to communicating timely real-world evaluations of our therapies to help answer relevant questions raised by the MS community."
About MAVENCLAD ®
MAVENCLAD ® is a short-course oral therapy that selectively and periodically targets lymphocytes thought to be integral to the pathological process of relapsing MS (RMS). In August 2017, the European Commission (EC) granted marketing authorization for MAVENCLAD ® for the treatment of relapsing forms of multiple sclerosis (RMS) in the 28 countries of the European Union (EU) in addition to Norway, Liechtenstein and Iceland. MAVENCLAD ® has since then been approved in over 80 countries, including Canada, Australia and the U.S. Refer to the respective prescribing information for further details.
The clinical development programme for cladribine tablets includes:
- The CLARITY (Cladribine Tablets Treating MS Orally) study: a two-year Phase III placebo-controlled study designed to evaluate the efficacy and safety of cladribine tablets as a monotherapy in patients with RRMS.
- The CLARITY extension study: a Phase III placebo-controlled study following on from the CLARITY study, which evaluated the safety and exploratory efficacy of cladribine tablets over two additional years beyond the two-year CLARITY study, according to the treatment assignment scheme for years 3 and 4.
- The ORACLE MS (Oral Cladribine in Early MS) study: a two-year Phase III placebo-controlled study designed to evaluate the efficacy and safety of cladribine tablets as a monotherapy in patients at risk of developing MS (patients who have experienced a first clinical event suggestive of MS).
- The ONWARD (Oral Cladribine Added ON to Interferon beta-1a in Patients With Active Relapsing Disease) study: a Phase II placebo-controlled study designed primarily to evaluate the safety and tolerability of adding cladribine tablets treatment to patients with relapsing forms of MS, who have experienced breakthrough disease while on established interferon-beta therapy.
- PREMIERE (Prospective Observational Long-term Safety Registry of Multiple Sclerosis) study: a long-term observational follow-up safety registry of MS patients who participated in cladribine tablets clinical studies.
In the two-year CLARITY study, the most commonly reported adverse event (AE) in patients treated with cladribine tablets was lymphopenia (26.7% with cladribine tablets and 1.8% for placebo). The incidence of infections was 48.3% with cladribine tablets and 42.5% with placebo, with 99.1% and 99.0% respectively rated mild-to-moderate by investigators. Adverse Events reported in other clinical studies were similar.
About Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory condition of the central nervous system and is the most common non-traumatic, disabling neurological disease in young adults. It is estimated approximately 2.8 million people have MS worldwide. While symptoms can vary, the most common symptoms of MS include blurred vision, numbness or tingling in the limbs and problems with strength and coordination. The relapsing forms of MS are the most common.
Merck in Neurology and Immunology
Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). The company`s current MS portfolio includes two products for the treatment of relapsing MS â€“ Rebif ® (interferon beta-1a) and MAVENCLAD ® (cladribine tablets). Merck aims to improve the lives of patients by addressing areas of unmet medical needs. In addition to Merck's commitment to MS, the company also have a pipeline focusing on discovering new therapies that have the potential in other neuroimmune diseases.
All Merck Press Releases are distributed by email at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 58,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices â€“ the company is everywhere. In 2019, Merck generated sales of â‚¬ 16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
Logo - https://mma.prnewswire.com/media/1136775/Merck_Logo.jpg
+49 151 1454 2694
More News by PR Newswire India
Damm and Ball launch world's first Aluminium Stewardship Initiative certified beverage cans
LimaCorporate And HSS Partner To Open First Provider-based Design And 3D Printing Center For Complex Joint Reconstruction Surgery
WhiteHat Jr.'s search for Tech Leaders steered by Purple Quarter
Ampersand Group successfully concludes digital intervention, development across Nashik Anganwadis
Siply Launches Affordable Gold Savings Scheme with High Returns for the Masses
Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity
Aavishkaar Group dedicates its Group Impact Report 2020 to 55 Million women leaders in its ecosystem
Feedback plc: International expansion with appointment of two industry specialists in India
LexisNexis Risk Solutions Study Reveals Financial Crime Compliance Costs Across Asia-Pacific Region Increased 20.6% Year Over Year
Eight Manga Artists' Works Exhibited at Kansai Airport Starting March 20
Asia Pacific banks are ready to take advantage of truly digital cores - delivering competitive advantages beyond cost
Citizenship by Investment Funded Real Estate Developments Will Bolster Dominica's Tourism Offering
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial
Cleaner, Clearer Pool and Spa Water
Gastops celebrates 3,500th engine sensor delivery for F-35 Lightning II
Amazfit T-Rex Pro: A Tough Military-grade Smartwatch with Endurance to Match Your Own and up to 18 Days' Battery Life
Rugged Military-Grade Smartwatch is the Ultimate Partner for Challenging Military-Grade Obstacle Course, Amazfit Partners with Spartan
Meitra Hospital Redefines its Brand Identity
Second Star-studded Hank's Home Game Sees Jokes, Jibes and Showdowns in the Name of Charity at PokerStars.net
Goa Introduces Olectra Electric Buses in its fleet
Haier's Healthy Air Conditioners Rank Number One in Three Prestigious Euromonitor International Categories
AeC Lauded by Frost & Sullivan for Employing a Mix of Technology and Human Expertise to further strengthen its position in the Brazilian Customer Experience Outsourcing Market
Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, AffronÂ®
HPE Lauded by Frost & Sullivan for Lowering the Risk of 5G Deployments
Uptake Recognized by Frost & Sullivan for Its Predictive Modeling Solutions for Medium-to-heavy-duty Vehicles
Brands are Redefining the Customer Experience by Adopting a Digital-first Approach
IIIT Hyderabad Announces M.Tech Program in Product Design and Management
U.S. Polo Assn. to Sponsor the Annual Lexus International Gay Polo Tournament Celebrating the Gay Polo League
Eagle Eye and Neptune Retail Solutions Enable a Better Digital Coupon Experience for Southeastern Grocers' Shoppers
Sinopec Signs Long-term Liquefied Natural Gas Deal of 2 Million Tons per Annum with Qatar Petroleum
Byogy Commissions Sustainable Low Carbon Jet Fuel Plant in Japan Advancing 'Alcohol to Jet' to Zero Carbon
Xinhua Silk Road: Changsha Economic and Technological Development Zone in C. China's Hunan unveils multiple measures to attract talents worldwide
AWE 2021: Haier Smart Home Brings Revolutionary Living Experience Empowered by its Smart Home Solution
New Research Reveals Top Investment Migration Program Options for HNWIs Seeking Health Security
V-Marc India Limited Initial Public Offering of Equity Shares opening on Thursday, March 25, 2021
Digital-First Tylko Raises â‚¬22 Million in Series C as Part of Its Commitment to Set New Standards in the Furniture Industry
Life Cycle Analysis of Corbion's AlgaPrimeâ„˘ DHA Validates Lower Carbon Footprint Compared to Traditional Sources of Fish Oil
Logiq Partners with Comviva to Offer Digital Wallet and Payment Services to Millions of Mobile Users Across Indonesia
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)
oneZero releases Algorithmic Pricing Module to give institutional clients even greater control
World Class Cocktail Festival: 2021 Homecoming
On World Water Day 2021, Sensus unveils exclusive whitepaper - 'Smart Cities need Smart Water'
Hexaware Technologies is Great Place to Work - certified
Ghodawat Consumer Earns a Prestigious Award; Bags 'India's Most Admirable Brand' Recognition
Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity
UST Provides Online Retail Platform Solution for UNIQLO India to Launch 'Shop From Home' Service
IAS Launches First Industry-Wide Digital Ad Verification Training Program
Bruce Lee's lost passion project 'The Silent Flute' to be produced by entrepreneur Jason Kothari
WZCC announces an exciting webinar with Mr. Piruz Khambatta, Chairman of Rasna, Hon. Consul General South Korea, Director GNFC, Chairman Rasna Foundation and Founder Trustee Areez Khambatta Benevolent Trust
HarperCollins is delighted to announce: Everything the Light Touches by Janice Pariat, publishing from Fourth Estate in October 2022
Crypto Liquidity Platform Black Ocean Opens Customer Whitelist
PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test
Global Semiconductor Materials Market Sets New High of $55.3 Billion With 5% Expansion in 2020, SEMI Reports
Catalyst Welcomes Accenture CEO Julie Sweet As New Board Chair
Frost & Sullivan Opens Nominations for Itron Excellence in Resourcefulness Awards
Squirrels Boosts AirPlay, Miracast and Google Cast With All-New Reflector 4
Stockholm International Water Institute: Freshwater Thought Leader Sandra Postel awarded 2021 Stockholm Water Prize
Astral Foundation helps Hiwali get its first water pipeline after independence
Sirtex Medical announces new SIR-SpheresÂ® DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma
Frost & Sullivan Experts Analyze Regional Tactics for Water and Sanitation for All by 2030
NEC Earns Acclaim from Frost & Sullivan for Adopting a Vector-based Approach to High-performance Computing with its SX-Aurora TSUBASA
Voyager Labs Partners with Microsoft to Provide AI SaaS Investigation Platforms to Empower Public Safety
Global Energy Prize 2021 - record number of participating countries
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
Summer Gold Coin Offer begins on KhelPlay Rummy
Planet Water Foundation Brings Life-Changing Access to Clean Drinking Water to Communities Across 5 Countries as Part of World Water Day Activation
RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India
Sonata Software to tap the Customer Experience (CX) Market to fuel growth
Mana Projects Celebrating 21 Years of Real Estate Excellence
Avaya Acclaimed by Frost & Sullivan for Seizing Growth Opportunities with its Robust Portfolio of Intelligent Contact Center Solutions
Glenmark and Bausch Health join together to commercialize RYALTRIS â„˘ nasal spray in Canada
AVEVA and OSIsoft Combine to Unlock the Potential of Data to Drive Increased Performance for Industrial Organizations
Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
Zalando Launches Spring Campaign to Laud Society's Champions & Celebrate Their Values
Hexaware Technologies Announces a Work Integrated Learning Program for Freshers
Empuls by Xoxoday integrates with Slack
India's Top Student Volunteers Felicitated At The 11th Annual Pramerica Spirit of Community Awards
Rajshri Entertainment to Make Its Wellness Content Available on Gaana as Podcasts
Plintron powers a unique educational initiative by SmartCentric
IBM Launches Fourth Annual Call for Code Global Challenge to Tackle Existential Threat of Climate Change
Product Analytics is the Number One Measurement of Digital Success, New Report By Harvard Business Review Analytic Services Sponsored by Amplitude Shows
SVKM's NMIMS Invites Applications for Post-Graduate Pharmacy Programs
PrettyLittleThing Turns Burj Khalifa Pink
Doctors Hospital Takes Action to Preserve Fair Competition After the Cayman Government Grants a Series of Financial Concessions
Maybelline New York Announces Storm Reid As Global Spokesmodel
The Craft Irish Whiskey Co. Sets the Record for the World's Most Expensive Whiskey Collection in Partnership With FabergĂ©
ZS PRIZE, a healthcare innovation programme, selects top 8 teams for jury evaluation and final winner announcement in April 2021
SUN Mobility and Zyngo partner to offer seamless last-mile delivery
India Nightlife Convention & Awards (INCA) concludes its 5th Edition in Goa
OKExChain welcomes Cosmostation validator node operator among six other partners to its rapidly expanding ecosystem
Voltas introduces the new 2021 range of Voltas Fresh Air Coolers; launches 'Ab Garmi Ke Mazey Lo, Bina Garmi Ke' campaign
Aster MIMS Calicut Offers Free Liver Transplant Surgeries to Children
'The Apprentice: ONE Championship Edition' to Premiere in India tomorrow, March 20th on Republic TV
APML issues pre-alert and guidelines to save innocent citizens from fake websites and fraudsters in packing and moving segment
GC to Increase Vinythai Shares through Delisting Tender Offer, Strengthening Downstream Chemicals Business, and Expanding Its Business in CLMV Market
Flexible workspaces to lease 3 million square feet of space in 2021: Colliers
RateGain Ranks in Deloitte Technology Fast50 For The Fifth Time
First Advantage launches Vendor Screening Solution
NMIMS Hyderabad Invites Applications for Common Entrance Tests - NMIMS- NPAT, NMIMS-CET and NMIMS-LAT - for Commerce, Pharmacy, & Law Programs
IAS Extends its Leadership in Brand Safety and Ad Fraud Protection with TAG Recertification
CITIC Networks Becomes Big Data Exchange (BDx) Connectivity Partner in Nanjing Data Center
ď»żApiJect Systems, Corp., Announces Appointment of Global Branding Leader, Craig Cohon as Chief Strategy Officer
EncoreÂ® Launches Hybrid+, Setting A Global Standard For Hybrid Meeting & Event Experiences
New Report Discusses IT/OT Convergence for Telcos
SDI Adds Acteev Protectâ„˘ Masks to Portfolio of PPE As-a-Service(SM)
The 129th Canton Fair Prepares for a Virtual Return from April 15-24, 2021
Hitachi launches new range of Room Air Conditioners for the new-age consumers: 'One for everyone'
Five Business Strategies to Ensure Environment Safety and Leverage eWaste Management
Huawei Recognized as a 2021 Gartner Peer Insights Customers' Choice for WAN Edge Infrastructure
"Charm of Jiangsu" celebrated the 2021 Chinese New Year with overseas fans online
GameAnalytics Joins Huawei Ecosystem as the Latest Platform Partner
Frost & Sullivan's India Manufacturing Excellence Awards 2021 to Honor Future-Ready Factories
Adani Green Energy raises USD 1.35 billion in one of Asia's largest project financing deals
Reliance Securities named as India's 10 most promising share trading platforms of 2020
QuerySurge is Now Available in the Microsoft Azure Marketplace
XCMG Celebrates International Day of Happiness, Champions Employee Wellbeing with its Upgraded Total Health Program
ZestMoney Ranked Second Fastest Growing Technology Company in Deloitte Technology Fast 50 India 2020
Firescore Interactive to launch the hyper-casual gaming hub 'CrazyHubs India' in partnership with CrazyLabs
Technical clothing requirements for armed forces likely to be included in negative import list; keen to procure indigenised techno textiles: General Bipin Rawat
Frost & Sullivan Identifies the Top 5 Growth Opportunities in the Next-Generation Connected Car Industry
Trimble Announces Release of Tekla 2021 Structural BIM Software Solutions
Nespresso invests CHF 117 million in the expansion of its Avenches production center to meet growing consumer demand
FDI - Dental disaster: One year after first lockdowns dentists around the world confront the consequences of the COVID-19 pandemic on people's oral health: higher incidence of tooth decay and more advanced gum disease
Aeijaz Sodawala, CEO eZee Technosys gives an industry insider view-point on the Google Free Booking Link Program
Skootr Launches Skootr FinSave, A New Company To Meet Growing Demand For Financial Services In The Office Segment
LYRA last-mile connectivity solution for rural India